Amgen Must Face Suit It Misled Investors On $10.7B Tax Bill
By David Hansen · October 1, 2024, 6:44 PM EDT
Amgen lost an attempt to escape a potential class action claiming the pharmaceutical giant hid a $10.7 billion tax bill from investors after a New York federal court ruled there was...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login